040760 UK Health- and Pharmaceutical Economics (BA) (2022S)
Continuous assessment of course work
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Mo 07.02.2022 09:00 to Mo 21.02.2022 23:59
- Deregistration possible until Mo 14.03.2022 23:59
Details
max. 30 participants
Language: German
Lecturers
Classes (iCal) - next class is marked with N
Friday
25.03.
13:15 - 18:15
Hörsaal 17 Oskar-Morgenstern-Platz 1 2.Stock
Saturday
26.03.
09:45 - 13:00
Hörsaal 17 Oskar-Morgenstern-Platz 1 2.Stock
Friday
06.05.
13:15 - 18:15
Hörsaal 17 Oskar-Morgenstern-Platz 1 2.Stock
Saturday
07.05.
09:45 - 13:00
Hörsaal 17 Oskar-Morgenstern-Platz 1 2.Stock
Friday
03.06.
13:15 - 18:15
Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
Saturday
04.06.
09:45 - 11:15
Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
Information
Aims, contents and method of the course
Assessment and permitted materials
Assigned Presentation (15 -20 Min)
Written final Exam
Written final Exam
Minimum requirements and assessment criteria
Presentation and exam both contribute 50% to final grade.
To achieve a positive grade in the test, at least 50% of the points in the written test are necessary
To achieve a positive grade in the test, at least 50% of the points in the written test are necessary
Examination topics
Reading list
Slide deck will be providedAdditional references:
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)
Association in the course directory
Last modified: Th 24.03.2022 18:28
• Forms of Delivery of Medical Care
• Paying Providers
• Physicians as Suppliers of Medical Services
• Austrian Health Care System
Literature:
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)Part 2: Health Economic Evaluation
• Health Technology Assessment (HTA) across countries
• Cost Effectiveness analysis
• Cost utility analysis
• Cost benefit analysis
• Comparative effectiveness
• Decision analytic modeling (e.g. Markov Models)
• Evidenced based Medicine
Literature:
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Additional reading:
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.Part 3 Pharmaceutical Economics
• The pharmaceutical Industry
• Pharmaceutical R&D process
• Costs and returns on pharmaceutical R&D
• Pricing Pharmaceuticals
• Pharmaceutical Regulation (e.g. patent legislation)
• Drug MarketingLiterature:
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)